tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Eco Animal Health CFO Exercises Deferred Share Options

Story Highlights
  • Eco Animal Health’s CFO exercised 4,309 deferred bonus share options with no new shares issued.
  • Total company share capital remains at 67,759,671 shares, ensuring no shareholder dilution.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Eco Animal Health CFO Exercises Deferred Share Options

Claim 50% Off TipRanks Premium and Invest with Confidence

Eco Animal Health ( (GB:EAH) ) just unveiled an update.

Eco Animal Health Group PLC announced that its CFO, Christopher Wilks, exercised 4,309 nominal cost share options tied to a deferred bonus scheme from 2022, with the transaction satisfied without issuing new shares and utilizing the company’s Employee Benefit Trust. The CFO’s total shareholding now represents approximately 0.26% of the company’s issued share capital, which remains unchanged overall at 67,759,671 shares, ensuring no dilution for shareholders and maintaining transparency for regulatory compliance.

The most recent analyst rating on (GB:EAH) stock is a Buy with a £123.00 price target. To see the full list of analyst forecasts on Eco Animal Health stock, see the GB:EAH Stock Forecast page.

Spark’s Take on GB:EAH Stock

According to Spark, TipRanks’ AI Analyst, GB:EAH is a Outperform.

Eco Animal Health’s overall stock score is driven by strong technical momentum and positive corporate events, indicating confidence in future growth. However, the high valuation and inconsistent financial performance temper the score, suggesting potential risks if growth expectations are not met.

To see Spark’s full report on GB:EAH stock, click here.

More about Eco Animal Health

Eco Animal Health Group PLC is a global leader in developing and marketing branded veterinary pharmaceuticals, with expertise in antibiotics and vaccines for pigs and poultry. Headquartered in the UK, the company operates globally, holds marketing authorizations in over 70 countries, employs over 200 people, and is recognized for its patented lead product Aivlosin®, which addresses respiratory and intestinal diseases in pigs and poultry.

Average Trading Volume: 75,561

Technical Sentiment Signal: Hold

Current Market Cap: £72.16M

Learn more about EAH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1